Medicare Enrolled

Sarah Case, APRN, FNP-C

Nurse Practitioner - Family · Deland, FL
1590 S SR 15A STE 100, Deland, FL 32720
3867740016
Registered in NPPES since 2020
NPI: 1922636851 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Case from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Case? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Case

Sarah Case is a nurse practitioner - family in Deland, FL, with 6 years of NPI registration.

Between the years covered by Open Payments, Case received a total of $3,274 from 26 pharmaceutical and/or device companies across 157 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Case is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 6 years of NPI registration $3,274 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Advanced Practice Registered Nurse 11016680 Clear April 30, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$3,274
Total received (2022-2024)
Avg $1,091/year across 3 years
Top 9% in FL for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
157
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,251
2023
$1,781
2022
$242

Payments by company (2024)

Novo Nordisk Inc
$367
ABBVIE INC.
$212
Amgen Inc.
$113
Lilly USA, LLC
$109
PFIZER INC.
$75
Phathom Pharmaceuticals, Inc.
$67
Exact Sciences Corporation
$48
Bayer Healthcare Pharmaceuticals Inc.
$40
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
Novartis Pharmaceuticals Corporation
$31
Janssen Pharmaceuticals, Inc
$29
Sumitomo Pharma America, Inc.
$24
Vanda Pharmaceuticals Inc.
$22
AstraZeneca Pharmaceuticals LP
$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Esperion Therapeutics, Inc.
$15
IDORSIA PHARMACEUTICALS US INC
$15
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 55.3% of 2024 payments
All-time payments by company (2022-2024) ›
ABBVIE INC.
$780
Novo Nordisk Inc
$762
Amgen Inc.
$376
Lilly USA, LLC
$335
PFIZER INC.
$116
Bayer Healthcare Pharmaceuticals Inc.
$95
Novartis Pharmaceuticals Corporation
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$84
AstraZeneca Pharmaceuticals LP
$84
KARL STORZ Endoscopy-America
$74
IMPEL PHARMACEUTICALS INC.
$71
Phathom Pharmaceuticals, Inc.
$67
Exact Sciences Corporation
$62
IDORSIA PHARMACEUTICALS US INC
$32
Otsuka America Pharmaceutical, Inc.
$32
Janssen Pharmaceuticals, Inc
$29
Antares Pharma, Inc.
$24
Sumitomo Pharma America, Inc.
$24
Vanda Pharmaceuticals Inc.
$22
Hollister Incorporated
$21
Xeris Pharmaceuticals, Inc.
$18
Janssen Biotech, Inc.
$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$16
Esperion Therapeutics, Inc.
$15
Shield Therapeutics Inc
$14
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 58.6% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AIRSUPRA · CAPLYTA · COMIRNATY · Cologuard Collection Kit · ELIQUIS · EMGALITY · ENTRESTO · ERLEADA · EVENITY · FARXIGA · GEMTESA · HETLIOZ · IMAGE1 S CONNECT · JARDIANCE · Kerendia · LEQVIO · MOUNJARO · NEXLETOL · NOCDURNA · NURTEC ODT · Otezla · Ozempic · PREVNAR 20 · QULIPTA · QUVIVIQ · RECORLEV · REXULTI · Repatha · Rybelsus · SPRAVATO · TRELEGY ELLIPTA · Trudhesa · UBRELVY · VOQUEZNA · VRAYLAR · VaPro Plus Pocket · Wegovy
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - family in Deland?
Compare family nurse practitioners in the Deland area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners in nearby ZIP areas
608
County median income
$66,581
Nearest hospital to ZIP centroid (approximate)
ADVENTHEALTH DELAND
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Case is a nurse practitioner - family.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Case receive payments from pharmaceutical companies?
Yes. Case received a total of $3,274 from 26 companies across 157 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Case) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →